On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Employs Three-Tiered Approach to Cannabis Market

  • Focus is on investing in and building vertically integrated portfolio in wholesale/retail, distribution and nutraceutical cannabis products for pets through legal cannabis ventures in North America
  • Holdings include North Road Ventures, an emerging distributor of cultivated and manufactured cannabis products and holder of a pending ACMPR application for a license amendment to sell, distribute cannabis and related products
  • Distribution strategy involves end-to-end, full cycle wholesale delivery

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically integrated cannabis company with strategic investments, continues its push to be ready for the green rush coming to Canada’s cannabis consumers. According to Statista, the medical marijuana market in Canada is projected to be worth C$1.1 billion in 2020 (http://cnw.fm/Mhg7B). Canadian lawmakers are poised to open the adult-use recreational cannabis market by the fall of 2018, which is expected to make the nation’s combined medical/recreational cannabis market worth about $2.8 billion by 2020 (new CIBC report states that the market for Canadian adult use cannabis will approach $6.5 billion in retail sales by 2020) (http://cnw.fm/7vEpb).

Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc. (“CCI”) to establish Good Manufacturing Practice (GMP)-compliant processes and procedures for producing its finished products (http://cnw.fm/P5kV7) . North Road has an application pending with Health Canada for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to distribute up to 7,500 kilos (16,500 pounds) of cannabis in its first year of operation.

Liberty Leaf expanded its portfolio in 2017 when it signed an agreement to develop up to four proprietary cannabidiol (“CBD”) formulations with ESEV Genetics R&D LLC, an American life sciences company researching cannabis and its role in medical solutions (http://cnw.fm/9aF2i). Together, Liberty Leaf and ESEV are working on a potentially very lucrative market – health and wellness for pets, specifically focusing on the efficacy of CBD pain management for canine osteoarthritis.

Liberty Leaf’s commitment to invest strategically in up-and-coming and established companies in the medicinal and recreational cannabis space is not relegated to Canada. The company is actively seeking to enter the various legal cannabis markets in North America, which Statista reports will bloom to more than $16 billion by 2020 (http://cnw.fm/mPi9E).  A recent Deloitte report estimates that legal weed could be a $22.6 billion industry in Canada alone (http://cnw.fm/QEj7K).

Liberty Leaf provides funding, management, HR resources and marketing expertise to help its investment holdings thrive and accelerate growth. Working relationships are formed with organizations engaged in research and development of cannabis uses, which also helps Liberty Leaf in its mission to expand and develop new markets.

For more information, visit the company’s website at www.LibLeaf.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722